Skip to main content
. 2022 Mar 30;13:863646. doi: 10.3389/fphar.2022.863646

FIGURE 10.

FIGURE 10

Diagram of miR-130a-3p on PF in inflammatory and fibrotic phases. In the inflammatory phase, activation of the NF-κB signaling pathway increases the expression of miR-130a-3p, while overexpression of miR-130a-3p inhibits LPS-induced production of TNF-α. In the fibrotic phase, TGF-β1 decreases miR-130a-3p expression through the TGF-β1/Smad pathway. Meanwhile, miR-130a-3p targets TGF-βRII and therefore inhibits the TGF-β1/Smad pathway.